Friends of Sheba Medical Center at Tel Hashomer


2010 show/hide
Sheba Partners with U of London Medical School to Launch International Medical Degree Program in CyprusDr. Norman Wall Awarded by Sheba: An Untold Medical Story from Israel's PastJoint effort leads to rehab clinic in Haitian capitaAnother Haitian patient healed at ShebaZabludowicz Center for Autoimmune Diseases Dedicated at the Sheba Medical CenterIsraeli hospitals train African doctors in AIDS treatmentsIraqi Child Saved at ShebaBereaved father transports ailing Palestinians to Israeli hospital (Sheba)Medical cannabis revolution in Israel, including ShebaCardiac research center holds promise for patients Israeli doctors arrive in Romania to treat babies burned in hospital fireSheba heart transplant patient has twins!For a Haitian amputee, life-changing aid is in sightIsraeli doctors in Congo to aid burn victims get slammed for occupationBaby saves mother from blood clot, at ShebaIsraeli doctors are first foreign specialists to treat victims of Congo oil blastSheba's Prof. Eli Schwartz pens new book on travelers and tropical diseasesSheba scientists: Teen-age Boys Have Greater Risk Than Girls Of High Blood Pressure As AdultsSheba's Prof. Achiron Preempts Multiple SclerosisSheba doctors: Experimental treatment successful in half of melanoma casesHouston forges cancer research links with Israel Israelis find MS signs that appear years before symptomsIsraeli team reports on return from 10-day Haiti missionSheba Proposes Establishment of Haitian-Israeli Rehabilitation Center in HaitiBorn-again Zionist supermodelBritish Medical Journal Discrimnates Against ShebaSheba and M. D. Anderson Sign Cooperation Agreement in Cancer Treatment and ResearchSheba Medical center teams up with University of TexasSheba's Colonel Dr. Itzik Kreiss Commands the Israeli Field Hospital in HaitiFive Sheba Doctors on Humanitarian Mission in HaitiSheba Medical Research Offers New Hope for Treating Childhood Leukemia
2009 show/hide
Sheba Scientists Publish Important Finding About Human Heart Stem CellsIsraeli medical team saves sight in MyanmarProf. Jacob Lavee's New Organ Donor Prioritization Plan Adopted into Law, and Draws International AttentionSheba's Prof. Raphi Walden Awarded the French Legion of HonorIsraeli Researchers Make Significant Progress in Heart Tissue EngineeringSheba's Dr. Jacob Kuint and colleagues find that postpartum depression negatively affects infant developmentSheba's Dr. Shai Izraeli discovers novel alternative to chemotherapy for children with leukemiaSheba, NYU researchers to draw genetic map of wandering JewA new school of thought: A plan to open the country's fifth medical school brings opportunities to re-think doctor trainingSarah Ferber of Sheba in Israel shows that potentially, patients with diabetes can be donors of their own therapeutic tissueStudy shows why simple carbs are bad for youStudy traces high carb link to heart attacksIn pursuit of a happiness geneUsing PlayStation to heal severe burn trauma Israel, PA and Jordan cooperate as flu threat grows Babies given transfusions in the womb do wellDecrease In Sense Of Smell Seen In Lupus PatientsSheba Doctor Publishes Inflammatory Breast Cancer Drug AdvanceSheba's Prof. Mordechai Shani to be Awarded Israel's Top Award: "The Israel Prize" for Lifetime Achievement The Last Soldier Goes Home Keep on giving: U.S. donor not deterred by financial downturnIsrael's first center for child abuse victims opens at Sheba Medical CenterInnovative cardiac valve prosthesis developed at ShebaHigher A1C Levels Linked to Lower Brain Function: Study Published by the American Diabetes Association Suggests Lowering A1C Levels Could Reduce Decline in Cognitive Function Gaza War Update II from Sheba Medical CenterIDF Chief-of-Staff Lt. Gen. Gabi Ashkenazi at Sheba: "I Thank Sheba for its Remarkable and Irreplaceable Work on Behalf of the Nation and its Soldiers!"Medical Update on the Gaza War'Not all Israelis are bad': Eight-year-old Palestinian cancer patient treated near Tel Aviv grateful to Israeli doctors
Sarah Ferber of Sheba in Israel shows that potentially, patients with diabetes can be donors of their own therapeutic tissue
Date07/13/2009
AuthorAndy Coghlan
SourceNew Scientist Magazine

A ONE-OFF treatment for diabetes is a step closer thanks to a better understanding of how human liver cells can be transformed into something like the beta cells that produce insulin in a healthy pancreas.

The new insights have allowed Sarah Ferber of the Sheba Medical Center in Tel Hashomer, Israel, and colleagues to implant these cells into diabetic monkeys. The ultimate plan is to take liver cells from people with diabetes, reprogram the cells and reinject them. Because they are the patient's own, the cells should escape rejection by the immune system, sparing the individual a lifetime of daily insulin injections. "Potentially, patients can be donors of their own therapeutic tissue," says Ferber.

In 2000, her team discovered that the Pdx-1 gene is crucial for the creation of the pancreas in the embryo. They went on to infect adult human liver cells with a harmless virus engineered to carry Pdx-1. The virus didn't insert the gene into the cells' DNA, but the liver cells produced Pdx-1 protein, enabling diabetic mice to manufacture insulin after injections of the altered cells.

Now the team has found out more about how Pdx-1 operates, which should eventually help them design a human treatment. By repeating the experiment and analysing the changes in gene expression as liver cells are transformed, the team showed that the gene deactivates a range of genes relevant to the cell's function in the liver, as well as activating unexpressed genes vital for beta cell function. A knowledge of this dual ability, which probably arises from the role Pdx-1 plays in the embryo, where pancreas and liver tissue develop from the same family of cells, will be important in predicting how the cells might act if they are implanted into people. Ferber is presenting the work on 9 July at an International Society for Stem Cell Research (ISSCR) meeting in Barcelona, Spain.

She also reports that the technique works best in liver cells that are in the process of multiplying. During cell division, chromosomes are exposed, which might make it easier for the Pdx-1 protein to alter their gene expression. Ferber has identified liver regions where dividing cells are more common, which should make reprogramming liver cells more efficient. The transformed cells do not seem to provoke the immune system.

Ferber's team is also looking for the best place for a transplant. Leading candidates, she says, are the liver and the omentum, the sac lining the abdomen.

Jonathan Slack of the University of Minnesota, Minneapolis, who has previously used Pdx-1 to turn frog liver tissue into beta cells, doubts whether Ferber's liver cells are completely changed into beta cells. "Rather, it may be the induction of some beta cell genes in liver cells," he suggests. But he points out that this could still have therapeutic value.

Last year, Doug Melton of Harvard University and colleagues reported that they had transformed a different type of specialist pancreatic cell into beta cells. Ferber says liver cells may be more practical because they are more abundant, easier to replace and more accessible.

Meanwhile, Harry Heimberg of the Vrije University of Brussels in Belgium reports at the ISSCR meeting that he is close to identifying elusive pancreatic stem cells in adult mice. If the same cells exist in humans, they might be activated to regenerate beta cells.

http://www.newscientist.com/article/mg20327164.300-liver-cells-could-be-reprogrammed-as-insulin-factories.html

  • T (310) 838-0700  F (310) 838-0717  E
  • Friends of Sheba Medical Center is a 501(c)3 tax exempt organization. Federal Tax ID 23-7076117.